NSE · DLF.NS
DLF Limited
₹690.55-₹3.80 (-0.55%)
DLF Limited’s quoted price sits in the upper half of its reported 52-week range, 12.02% below the high.
Loading market information…
NSE · ALEMBICLTD.NS · INR
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 05:45 AM UTC. Cached market data; not a live quote.
One-year closing-price history · INR. Historical prices are not a forecast.
Alembic Limited’s quoted price sits in the lower half of its reported 52-week range, 25.55% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Alembic Limited’s forward annual dividend is ₹2.40 per share, paid annual. The forward yield is 2.74% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Alembic Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Alembic Limited primarily manufactures and globally distributes active pharmaceutical ingredients (APIs) developed through both fermentation and chemical synthesis. The company operates across two distinct divisions: API and Real Estate. In its real estate ventures, Alembic undertakes the construction of residential and commercial properties, offers project management and marketing consultancy services, and leases commercial spaces. Furthermore, it operates its own power generation facilities, including co-generation plants with a total capacity of 11 MW and wind power plants contributing 5 MW. Founded in 1907 and headquartered in Vadodara, India, Alembic Limited is a subsidiary of Nirayu Limited.
Latest available per-share figures in INR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:45 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₹690.55-₹3.80 (-0.55%)
DLF Limited’s quoted price sits in the upper half of its reported 52-week range, 12.02% below the high.
₹1,034.60-₹11.20 (-1.07%)
Lodha Developers Limited’s quoted price sits in the upper half of its reported 52-week range, 23.08% below the high.
₹113.35-₹5.96 (-5.0%)
Morepen Laboratories Limited’s quoted price sits in the upper half of its reported 52-week range, 24.78% below the high.
₹180.12-₹4.81 (-2.6%)
IOL Chemicals and Pharmaceuticals Limited’s quoted price sits in the upper half of its reported 52-week range, 19.59% below the high.
₹517.35+₹31.55 (+6.49%)
SMS Pharmaceuticals Limited’s quoted price sits in the upper half of its reported 52-week range, 1.5% below the high.
₹1,786.30-₹26.50 (-1.46%)
Evonile Pharma Limited’s quoted price sits in the upper half of its reported 52-week range, 31.0% below the high.
₹637.05-₹18.20 (-2.78%)
Solara Active Pharma Sciences Limited’s quoted price sits in the upper half of its reported 52-week range, 17.69% below the high.
₹207.05-₹2.45 (-1.17%)
Indoco Remedies Limited’s quoted price sits in the lower half of its reported 52-week range, 28.11% below the high.
